GLYCOSYN

Founded in 2002, Glycosyn was formed to commercialize discoveries that arose during three decades of pioneering academic research by its three scientific founders, David Newburg, PhD, Boston College; Ardythe Morrow, PhD, Cincinnati Children's Research Foundation; and Guillermo Ruiz-Palacios, MD, Instituto Nacional de Ciencias Medicas y Nutricion-Mexico. They discovered natural, anti-infective components (glycans) in human breast milk and demonstrated that these components provide significant protection against infectious diarrhea. In 2007 Glycosyn hired John McCoy, PhD, a senior industry professional with over 30 years' experience in biotechnology and biopharmaceuticals, as Chief Scientific Officer and established laboratory facilities in Massachusetts, USA. Dr. McCoy and his team has since successfully developed economic, scalable technology for the large scale production of Glycosyn's principal products; the human milk oligosaccharides (hMOS), and has developed intellectual property..

Also known as: Glycosyn LLC, Glycosyn, Inc.

Primary location: Woburn United States